8.7
HIGH CVSS 4.0
CVE-2023-53734
dawa-pharma-1.0 - SQL Injection via Email Parameter
Description

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

INFO

Published Date :

Dec. 4, 2025, 9:16 p.m.

Last Modified :

Dec. 4, 2025, 9:16 p.m.

Remotely Exploit :

Yes !
Affected Products

The following products are affected by CVE-2023-53734 vulnerability. Even if cvefeed.io is aware of the exact versions of the products that are affected, the information is not represented in the table below.

ID Vendor Product Action
1 Mayurik best_pharmacy_billing_software
CVSS Scores
The Common Vulnerability Scoring System is a standardized framework for assessing the severity of vulnerabilities in software and systems. We collect and displays CVSS scores from various sources for each CVE.
Score Version Severity Vector Exploitability Score Impact Score Source
CVSS 4.0 HIGH 83251b91-4cc7-4094-a5c7-464a1b83ea10
CVSS 4.0 HIGH [email protected]
Solution
Prevent SQL injection by validating all user inputs and using parameterized queries.
  • Validate all user inputs for SQL injection.
  • Use parameterized queries or prepared statements.
  • Sanitize all data before executing SQL queries.
  • Restrict database user privileges.
CWE - Common Weakness Enumeration

While CVE identifies specific instances of vulnerabilities, CWE categorizes the common flaws or weaknesses that can lead to vulnerabilities. CVE-2023-53734 is associated with the following CWEs:

We scan GitHub repositories to detect new proof-of-concept exploits. Following list is a collection of public exploits and proof-of-concepts, which have been published on GitHub (sorted by the most recently updated).

Results are limited to the first 15 repositories due to potential performance issues.

The following list is the news that have been mention CVE-2023-53734 vulnerability anywhere in the article.

The following table lists the changes that have been made to the CVE-2023-53734 vulnerability over time.

Vulnerability history details can be useful for understanding the evolution of a vulnerability, and for identifying the most recent changes that may impact the vulnerability's severity, exploitability, or other characteristics.

  • New CVE Received by [email protected]

    Dec. 04, 2025

    Action Type Old Value New Value
    Added Description dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
    Added CVSS V4.0 AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
    Added CWE CWE-89
    Added Reference https://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/mayuri_k/2022/dawa-pharma-1.0-2022
    Added Reference https://www.exploit-db.com/exploits/51818
    Added Reference https://www.mayurik.com/source-code/P0349/best-pharmacy-billing-software-free-download
    Added Reference https://www.nu11secur1ty.com/
    Added Reference https://www.vulncheck.com/advisories/dawa-pharma-10-sql-injection-via-email-parameter
EPSS is a daily estimate of the probability of exploitation activity being observed over the next 30 days. Following chart shows the EPSS score history of the vulnerability.
Vulnerability Scoring Details
Base CVSS Score: 8.7
Attack Vector
Attack Complexity
Attack Requirements
Privileges Required
User Interaction
VS Confidentiality
VS Integrity
VS Availability
SS Confidentiality
SS Integrity
SS Availability